Hi everyone, few days ago I've talked to pharm analyst and his opinion is as follows:
1 The level of response is average, the most important is a survival rate which they don't publish while survival rate was declared as the main goal of the trials.
2 We know about 2 survivals who also had marrow transplantation. And we don't know exactly what showed such a result.
3 The trials with 10 persons in Israel do not mean anything for the US as well as previous trials of 90's when there were other standards.
4 Today cell therapy is being widly developed and there is no point to develop old technology within next 3-5 years.
5 Moreover Race has no funds for FDA in US with average cost of 50mln $.
What do you think of this
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
-0.030(1.94%) |
Mkt cap ! $258.9M | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.57 | $1.50 | $75.34K | 49.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 49256 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |